Chijian Zuo

Title: Chijian Zuo: Innovator in Circular RNA Technology

Introduction

Chijian Zuo is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant nucleic acid molecules. With a total of 3 patents, his work focuses on innovative methods for preparing circular RNA, which has important applications in various medical fields.

Latest Patents

Chijian Zuo's latest patents include groundbreaking technologies related to recombinant nucleic acid molecules. One of his notable inventions is a recombinant nucleic acid molecule and its application in the preparation of circular RNA. This invention introduces a Clean PIE system with a novel structure that enhances the accuracy of circular RNA molecules while reducing their immunogenicity. This technology holds promise for applications in nucleic acid vaccines, therapeutic protein expression, and gene therapy.

Another significant patent by Zuo involves a recombinant nucleic acid molecule based on point mutation of translation initiation elements. This invention also contributes to the preparation of circular RNA and offers a novel Clean PIE system for in vitro applications. It aims to improve the sequence accuracy of circular RNA and reduce changes in its secondary structure, further enhancing its potential in therapeutic applications.

Career Highlights

Chijian Zuo is currently associated with Purecodon (Hong Kong) Biopharma Ltd., where he continues to advance his research in biotechnology. His work is characterized by a commitment to innovation and the development of technologies that can significantly impact the medical field.

Collaborations

Zuo collaborates with esteemed colleagues such as Zhenhua Sun and Zonghao Qiu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chijian Zuo is a leading inventor in the field of circular RNA technology, with a focus on developing recombinant nucleic acid molecules that have the potential to revolutionize medical treatments. His contributions are paving the way for advancements in gene therapy and vaccine development.